Lidocaine Hydrochloride Jelly USP 2% (5 mL and 30 mL)

The listing of inactive ingredients in the DESCRIPTION section of the package insert appears to be consistent with the listing of inactive ingredients found in the statement of components and composition appearing on page 132 (Volume 1.1). However, see the comment (b) under ... but she is not sure. She said she ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download